Ajax-Loading

Sanofi SA - Ebitda Per Share

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR.

The item "Ebitda-Per-Share" stands at 9.95 Euros as of 09/30/2025.

As of the end of Sanofi SA's third quarter, the item "Ebitda Per Share" stands at 9.95 EUR. This represents a decrease of -4.72 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.30 percent compared to the value the year prior.
The 1 year change in percent is 16.30.
The 3 year change in percent is -7.57.

The Serie's long term average value is 9.81 Euros. It's latest available value, on 09/30/2025, is 1.41 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +26.48%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -13.17%.

Ebitda Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Per Share905,699,262,464.00
LogoJohnson & Johnson - Ebitda Per Share486,508,953,600.00
LogoAbbVie Inc - Ebitda Per Share399,570,305,024.00
LogoRoche Holding AG - Ebitda Per Share317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Per Share280,205,508,085.11